Using bioinformatics for drug target identification from the genome

American Journal of PharmacoGenomics

Volumn 5, Issue 6, 2005, Pages 387-396

  Jiang, Zhenran ^a   Zhou, Yanhong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; HORMONE RECEPTOR; ION CHANNEL; PHOSPHOTRANSFERASE; PROTEINASE;

BIOINFORMATICS; BIOLOGY; DISEASE MODEL; DRUG TARGETING; GENE FUNCTION; GENETIC PROCEDURES; GENOMICS; PHARMACOGENOMICS; PREDICTION; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ALZHEIMER DISEASE; ANIMALS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; DRUG DELIVERY SYSTEMS; DRUG DESIGN; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOMICS; HUMANS; ION CHANNELS; MOLECULAR BIOLOGY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, G-PROTEIN-COUPLED; XENOBIOTICS;

EID: 28944454885     PISSN: 11752203     EISSN: 11752203     Source Type: Journal    
DOI: 10.2165/00129785-200505060-00005     Document Type: Review

References (104)

1. Drews J. Genomic sciences and the medicine of tomorrow. Nat Biotechnol 1996; 14: 1516-8
2. Drews J. Drug discovery: a historical perspective. Science 2000; 287: 1960-4
3. Terstappen GC, Reggiani A. In silico research in drug discovery. Trends Pharmacol Sci 2001; 22: 23-6
4. International Human Genome Sequence Consortium. Finishing the euchromatic sequence of the human genome. Nature 2004; 431: 931-45
5. Zambrowicz BP, Sands AT. Knockouts model the 100 best-selling drugs: will they model the next 100? Nat Rev Drug Discov 2003; 2: 38-51
6. Searls DB. Using bioinformatics in gene and drug discovery. Drug Discov Today 2000; 4: 135-43
7. Whittaker PA. What is the relevance of bioinformatics to pharmacology? Trends Pharmacol Sci 2003; 24: 434-9
8. Dahl SG, Kristiansen K, Sylte I. Bioinformatics: from genome to drug targets. Ann Med 2002; 34: 306-12
9. Allison DB. Statistical methods for microarray research for drug target identifica-tion 2002. Proceedings of the American Statistical Association, Biopharmaceutical Section [CD-ROM]. Alexandria (VA): American Statistical Association, 2002
10. Sands AT. The rule of three: selecting the best new drug targets. Drug Discovery & Development 2003 Mar [online]. Available from URL: http://www.ddd-mag.com/ [Accessed 2005 Oct 10]
11. Drews J, Ryser S. Classic drug targets. Nat Biotechnol 1997; 15: 1318-9
12. Bouvier M. Structural and functional aspects of G protein-coupled receptor oligomerization. Biochem Cell Biol 1998; 76: 1-11
13. Nambi P, Aiyar N. G protein-coupled receptors in drug discovery. Assay Drug Dev Technol 2003; 1: 305-11
14. Fredriksson R, Schioth HB. The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol Pharmacol 2005; 67: 1414-25
15. Palczewski K, Kumasaka T, Hori T, et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 2000; 289: 739-45
16. Clapham DE. TRP channels as cellular sensors. Nature 2003; 426: 517-24
17. Terstappen GC. Ion channel screening technologies today. Drug Discov Today 2005; 2: 133-40
18. Cahalan MD, Chandy KG. Ion channels in the immune system as targets for immunosuppression. Curr Opin Biotechnol 1997; 8: 749-56
19. Bennett PB, Guthrie HRE. Trends in ion channel drug discovery: advances in screening technologies. Trends Biotechnol 2003: 21, 563-9
20. Duarte J, Perriére G, Laudet V, et al. NUREBASE: database of nuclear hormone receptors. Nucl Acids Res 2002; 30: 364-8
21. Inpharmatica successfully closes GBP13.9m (USD25m) third round financing. 2004 Nov 8 [press release; online]. Available from URL: http://www. inpharmatica.com/news/2004/081104.htm [Accessed 2005 Nov15]
22. Docherty AJ, Crabbe T, O'Connell JP, et al. Proteases as drug targets. Biochem Soc Symp 2003; 70: 147-61
23. Leung D, Abbenante G, Fairlie DP. Protease inhibitors: current status and future prospects. J Med Chem 2000; 43: 305-41
24. Cohen P. Protein kinases: the major drug targets of the twenty-first century. Nat Rev Drug Discov 2002; 1: 309-15
25. Shears SB. Rounding up the usual suspects: protein kinases as therapeutic targets. Drug Discovery Today 2005; 10: 240-2
26. Lau LF, Seymour PA, Sanner MA, et al. Cdk5 as a drug target for the treatment of Alzheimer's disease. J Mol Neurosci 2002; 19 (3): 267-73
27. Smith C. Drug target identification: a question of biology. Nature 2004; 428: 225-31
28. Augen J. The evolving role of information technology in the drug discovery process. Drug Discov Today 2002; 7: 315-23
29. Head-Gordon T, Wooley JC. Computational challenges in structural and functional genomics. IBM Systems J 2001; 40 (2): 265-96
30. Horn F, Bettler E, Oliveira L, et al. GPCRDB information system for G protein-coupled receptors. Nucleic Acids Res 2003; 31: 294-7
31. Le Novére N, Changeux J-P. LGICdb: the ligand-gated ion channel database. Nucleic Acids Res 2001; 29: 294-5
32. IUPHAR receptor database [online]. Available from URL: http://www.iuphardb.org/iuphar-rd [Accessed 2005 Oct 10]
33. Rawlings ND, O'Brien E, Barrett AJ. MEROPS: the protease database. Nucleic Acids Res 2002; 30: 343-6
34. Krupa A, Abhinandan KR, Srinivasan N. KinG: a database of protein kinases in genome. Nucleic Acids Res 2004; 32: 153-5
35. Horn F, Vriend G, Cohen FE. Collecting and harvesting biological data: the GPCRDB and NucleaRDB information systems. Nucleic Acids Res 2001; 29: 346-9
36. Duarte J, Perriére G, Laudet V, Robinson-Rechavi M. NUREBASE: database of nuclear hormone receptors Nucleic Acids Res 2002; 30: 364-368
37. Chen X, Ji ZL, Chen YZ. TTD: therapeutic target database. Nucleic Acids Res 2002; 30: 412-5
38. Aureus Pharma website [online]. Available from URL: http://www.aureus- pharma.com [Accessed 2005 Oct 10]
39. LifeSpan Biosciences website [online]. Available from URL: http://www.lsbio.com [Accessed 2005 Oct 10]
40. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000; 28: 27-30
41. Zheng CJ, Zhou H, Xie B, et al. TRMP: a database of therapeutically relevant multiple-pathways. Bioinformatics 2004; 20 (14): 2236-41
42. Krieger CJ, Zhang P, Mueller LA, et al. MetaCyc: a multiorganism database of metabolic pathways and enzymes. Nucleic Acids Res 2004; 32: 438-42
43. Goto S, Okuno Y, Hattori M, et al. LIGAND: database of chemical compounds and reactions in biological pathways. Nucleic Acids Res 2002; 30: 402-4
44. Hamosh A, Scott AF, Amberger J, et al. Online mendelian inheritance in man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 2002; 30: 52-5
45. Human Protein Interaction Database [online]. Available from URL: http://www.hpid.org [Accessed 2005 Oct 10]
46. PhRMA website [online]. Available from URL: http://www.phrma.org/ [Accessed 2005 Oct 10]
47. Bader GD, Betel D, Hogue CWV. BIND: the biomolecular interaction network database. Nucleic Acids Res 2003; 31: 248-50
48. Heart High-Performance 2-DE Database [online]. Available from URL: http://www.mdc-berlin.de/∼emu/heart/ [Accessed Nov 15]
49. Hewett M, Oliver DE, Rubin DL, et al. PharmGKB: the pharmacogenetics knowledge base. Nucleic Acids Res 2002; 30: 163-5
50. Foord SM. Receptor classification: post genome. Curr Opin Pharmacol 2002; 2: 561-6
51. Manning G, Whyte DB, Martinez R, et al. The protein kinase complement of the human genome. Science 2002; 298: 1912-34
52. Lapinsh M, Gutcaits A, Prusis P, et al. Classification of G-protein coupled receptors by alignment-independent extraction of principal chemical properties of primary amino acid sequences. Protein Sci 2002; 11: 795-805
53. Takeda S, Kadowaki S, Haga T, et al. Identification of G protein-coupled receptor genes from the human genome sequence. FEBS Lett 2002; 520: 97-101
54. Karchin R, Karplus K, Haussler D. Classifying G-protein coupled receptors with support vector machines. Bioinformatics 2002; 18: 147-59
55. Bhasin M, Raghava GP. GPCRpred: an SVM-based method for prediction of families and subfamilies of G-protein coupled receptors. Nucleic Acids Res 2004; 32: W383-9
56. Sugiyama Y, Poluliakh N, Shimizu T. Identification of transmembrane protein functions by binary topology patterns. Protein Eng 2003; 16: 479-88
57. Inoue Y, Ikeda M, Shimizu T. Proteome-wide classification and identification of mammalian-type GPCRs by binary topology pattern. Comput Biol Chem 2004; 28: 39-49
58. Zhou YH, Yang L, Wang H, et al. Prediction of eukaryotic gene structures based on multilevel optimization. Chin Sci Bull 2004; 49 (4): 321-8
59. Adams MD, Kerlavage AR, Fields C, et al. 3,400 new expressed sequence tags identify diversity of transcripts in human brain. Nat Genet 1993; 4: 256-67
60. Allikmets R, Gerrard B, Glavac D, et al. Characterization and mapping of three new mammalian ATP-binding transporter genes from an EST database. Mamm Genome 1995; 6: 114-7
61. Boguski MS, Lowe TM, Tolstoshev CM. dbEST: database for "expressed sequence tags". Nat Genet 1993; 4 (4): 332-3
62. Wittenberger T, Schaller HC, Hellebrand S. An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors. J Mol Biol 2001; 307: 799-813
63. Marvanová M, Tör̈onen P, Storvik M, et al. Synexpression analysis of ESTs in the rat brain reveals distinct patterns and potential drug targets. Mol Brain Res 2002; 104: 176-83
64. Zhou YH, Jing H, Li YE, et al. Identification of true EST alignments and exon regions of gene sequences. Chin Sci Bull 2004; 49 (23): 2463-9
65. Aggarwal K, Lee KH. Functional genomics and proteomics as a foundation for systems biology. Brief Funct Genomic Proteomic 2003; 2: 175-84
66. Gabaldon T, Huynen MA. Prediction of protein function and pathways in the genome era. Cell Mol Life Sci 2004; 61: 930-44
67. Hennig S, Groth D, Lehrach H. Automated gene ontology annotation for anonymous sequence data. Nucleic Acids Res 2003; 31: 3712-5
68. Jensen LJ, Gupta R, Staerfeldt HH, et al. Prediction of human protein function according to gene ontology categories. Bioinformatics 2003; 19: 635-42
69. Schug J, Diskin S, Mazzarelli J, et al. Predicting gene ontology functions from ProDom and CDD protein domains. Genome Res 2002; 12: 648-55
70. Guffanti A. Modeling molecular networks: a systems biology approach to gene function. Genome Biol 2002; 3 (10): 4031.1-4031.3
71. Meltzer PS. Spotting the target: microarrays for disease gene discovery. Curr Opin Genet Dev 2001; 11: 258-63
72. Marton MJ, De Risi JL, Bennet HA, et al. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat Med 1998; 4: 1293-301
73. Miklos GL, Maleszka R. Microarray reality checks in the context of a complex disease. Nat Biotechnol 2004; 22: 615-21
74. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001; 98: 5116-21
75. Schulze A, Downward J. Navigating gene expression using microarrays: a technology review. Nat Cell Biol 2001; 3: E190-5
76. Draghici S, Khatri P, Martins RP, et al. Global functional profiling of gene expression. Genomics 2003; 81: 98-104
77. Volinia S, Evangelisti R, Francioso F, et al. GOAL: automated Gene Ontology analysis of expression profiles. Nucleic Acids Res 2004; 32: W492-9
78. Wang WQ, Zhou YH, Bi R. Correlating genes and functions to diseases by systematic differential analysis of expression profiles. Lecture Notes Comput Sci 2005; 3645: 11-20
79. Pericak-Vance MA, Yamaoka LH, Haynes CS, et al. Genetic linkage studies in Alzheimer's disease families. Exp Neurol 1988; 102: 271-9
80. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-3
81. Freudenberg J, Propping P. A similarity-based method for genome-wide prediction of disease-relevant human genes. Bioinformatics 2002; 18 Suppl. 2: S110-5
82. Van Driel MA, Cuelenaere K, Kemmeren PP, et al. A new web-based data mining tool for the identification of candidate genes for human genetic disorders. Eur J Hum Genet 2003; 11: 57-63
83. Perez-Iratxeta C, Bork P, Andrade MA. Association of genes to genetically inherited diseases using data mining. Nat Genet 2002; 31: 316-9
84. Zhou YH, Zhou QX, Liu HL, et al. Predicting disease genes for familial dilated cardiomyopathy based on the codon usage bias. Chin Sci Bull 2005; 50 (18): 2028-32
85. Pettipher R, Mangion J, Hunter MG. et al. Identification of G-protein-coupled receptors involved in inflammatory disease by genetic association studies. Curr Opin Pharmacol 2005: 5, 412-7
86. Richard M, Bruskiewich AB, Cosico WE, et al. Linking genotype to phenotype: the International Rice Information System (IRIS). Bioinformatics 2003; 19: 63-5
87. Lindpaintner K. Science and society: the impact of pharmacogenetics and pharmacogenomics on drug discovery. Nature Rev Drug Discovery 2002; 1: 463-9
88. Lindpaintner K. Pharmacogenetics and pharmacogenomics in drug discovery and development: an overview. Clin Chem Lab Med 2003; 41 (4): 398-410
89. Campbell DA, Valdes AM, Spurr N. Making drug discovery a SN(i)P. Drug Discov Today 2000; 5: 388-96
90. Evans WE, McLeod HL. Pharmacogenomics: drug disposition, drug targets, and side effects. N Engl J Med 2003; 348: 538-49
91. Cabusora L, Sutton E, Fulmer A, et al. Differential network expression during drug and stress response. Bioinformatics 2005; 21: 2898-905
92. Shmulevich I, Dougherty ER, Kim S, et al. Probabilistic Boolean networks: a rule-based uncertainty model for gene regulatory networks. Bioinformatics 2002; 18: 261-74
93. Akutsu T, Miyano S, Kuhara S. Inferring qualitative relations in genetic networks and metabolic pathways. Bioinformatics 2000; 16: 727-34
94. Imoto S, Savoie CJ, Aburatani S, et al. Use of gene networks for identifying and validating drug targets. J Bioinform Comput Biol 2003; 1: 459-74
95. Gardner TS, di Bernardo D, Lorenz D, et al. Inferring gene networks and identifying compound mode of action via expression profiling. Science 2003; 301: 102-5
96. Stagljar I, Hottiger MO, Auerbach D, et al. Protein-protein interactions as a basis for drug target identification. Innov Pharm Technol 2002; 1: 66-9
97. Rain JC, Selig L, De Reuse H, et al. The protein-protein interaction map of Helicobacter pylori. Nature 2001; 409: 211-5
98. Luan Y, Li H. Model-based methods for identifying periodically expressed genes based on time course microarray gene expression data. Bioinformatics 2004; 20: 332-9
99. Nariai N, Kim S, Imoto S, et al. Using protein-protein interactions for refining gene networks estimated from microarray data by Bayesian networks. Pac Symp Sympos Biocomput World Sci 2004; 9: 336-47
100. Bader JS, Chaudhuri A, Rothberg JM, et al. Gaining confidence in high-throughput protein interaction networks. Nat Biotechnol 2004; 22: 78-85
101. Butcher EC, Berg EL, Kunkel EJ. Systems biology in drug discovery. Nat Biotechnol 2003; 22: 1253-9
102. Hood L, Galas D. The digital code of DNA. Nature 2003; 421: 444-8
103. Nicholson JK, Wilson ID. Understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2004; 2: 668-76
104. Parsons AB, Brost RL, Ding H, et al. Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat Biotechnol 2003; 22: 62-9